1.
Br J Dermatol
; 179(3): 787-789, 2018 09.
Article
in English
| MEDLINE
| ID: mdl-29624637
Subject(s)
Adalimumab/therapeutic use , MicroRNAs/blood , Psoriasis/drug therapy , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adalimumab/pharmacology , Adult , Aged , Biomarkers/blood , Biomarkers/metabolism , Case-Control Studies , Epigenesis, Genetic/drug effects , Feasibility Studies , Female , Healthy Volunteers , Humans , Leukocytes, Mononuclear/metabolism , Male , MicroRNAs/metabolism , Middle Aged , Psoriasis/blood , Psoriasis/pathology , Skin/drug effects , Skin/pathology , Treatment Outcome , Young Adult
2.
J Am Vet Med Assoc
; 200(7): 961-3, 1992 Apr 01.
Article
in English
| MEDLINE
| ID: mdl-1577651
ABSTRACT
Serratia marcescens was the causative agent of bacterial endocarditis in a 2-year-old Arabian stallion. The horse was treated with broad-spectrum antibiotics for 1 month. The horse died several months after treatment was discontinued. To our knowledge, Serratia marcescens has not been reported as the cause of bacterial endocarditis in horses; however, multiple cases of bacterial endocarditis attributable to Serratia marcescens have been documented in human beings. The bacteria is most commonly isolated in immune-compromised patients.
